Correlation of immunohistochemically detected HER-2/neu (c-erbB-2) with histological stage and perineural invasion in pancreatic cancer

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 334-337

  Tamiolakis, D ^a   Venizelos, I ^b   Simopoulos, C ^b   Kotini, A ^b   Jivannakis, T ^c   Papadopoulos, N ^b  

^a Chania General Hospital St George   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c General Hospital of Drama   (Greece)

Author keywords

HER 2 neu oncoprotein; Histological stage; Immunohistochemistry; Pancreatic cancer; Perineural invasion

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN; PEROXIDASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PERINEURIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PERINEUM;

EID: 1842431104     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49:3713-3721.
2. van de Vijver M, van de Beraselaar R, Devilee P, et al: Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is also often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 1987; 7:2019-2023.
3. Akiyama T, Sudo C, Ogawara H, et al: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232:1644-1646.
4. Schechter AL, Stern DF, Vaidyanathan L, et al: The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumor antigen. Nature 1984; 312:513-516.
5. Berger MS, Locher GW, Saurer S et al: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48:1238-1243.
6. Venter DJ, Tuzi NL, Kumar S, et al: Overexpression of the c-erbB-2 protein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 1987; 2:69-72.
7. Koka V, Potti A, Koch M, Fraiman G, Mehdi S, Levitt R: Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpresaon in pancreatic carcinoma. Anticancer Res 2002; 22(3):1593-1597.
8. Geer RJ, Brennam MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165:68-73.
9. Sperti C, Bonadimani B, Pasquali C, et al: Ductal adenocarcinoma of the pancreas: Clinicopathologic features and survival. Tumori 1993; 79(5):325-330.
10. Griffanti-Bartoli F, Arnone GB, Ceppe P, et al: Malignant tumors in the head of the pancreas and the periampullary region: Diagnostic and prognostic aspects. Anticancer Res 1994; 14:657-666.
11. Nagakawa T, Mori K, Nakano T, et al: Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 1993; 80:619-621.
12. Kayahara M, Nagakawa T, Ueno K, et al: Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 1995; 117:616-623.
13. Fortner JG, Kim DK, Cubilla, et al: Regional pancreatectomy: en bloc pancreatic, portal vein, and lymph node resection. Ann Surg 1977; 186:42-50.
14. Jentzer A: Neurotropisme des cellules cancerreuses clinique et therapeutique des cancers neurotropes. Ann J Cancer 1932; 16:37.
15. Hassan MO, Maksem J: The prostatic perineural space and its relation to tumor spread. Am J Surg Pathol 1980; 4:143-148.
16. Bock P, Hanak H: Die verteilung exogener peroxydase im endoneuralraum. Histochemie 1971; 25:361-371.
17. Nakao A, Harada A, Nonami T, et al: Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996; 12:357-361.
18. Takahashi T, Ishikura H, Motohara T, et al: Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997; 65:164-170.
19. Nagakawa T, Kayahara M, Ueno K, et al: A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer 1992; 69:930-93.
20. Nagayo T, Murakami N, Matuoka Y: Local neural invasion of carcinoma of the gallbladder, the bile and the pancreas. Clin Cancer 1976; 186:42-50.
21. Matsuda M, Nimura Y: Perineural invasion of carcinoma of the head of the pancreas. Jpn J Surg 1983; 84:719-728.
22. Kenmotsu M: Relationship between perineural invasion and expression of neuroendocrine markers and neural cell adhesion molecule in human pancreatic carcinoma. Jpn J Gastroenterol Surg 1990; 23:2580-2585.
23. Kayahara M: Clinicopathologic and experimental studies on the spread of the pancreatic cancer: neural invasion in the extrapancreatic plexus. Jpn J Gastroenterol Surg 1988; 21:1363-1372.
24. Cameron JL, Crist DW, Sitzmann JV, et al: Factors influencing survival after pancreatoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120-125.
25. Drapiewski JF: Carcinoma of the pancreas: a study of neoplastic invasion of nerves and its possible clinical significance. Am J Clin Pathol 1944; 12:549-556.
26. Magari S: Extravascular pathway and the lymphatics with special reference to the perineural infiltration of pancreatic cancer. Tan to Sui (Bile Duct and Pancreas) 1991; 12:121-127.
27. Ishida T, Taujisaki M, Hanzawa Y, Hirakawa T, Hinoda Y, Imai K, et al: Significance of erbB-2 gene product: as a target molecule for cancer therapy. Scand J Immunol 1994; 39:459-466.
28. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT: The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000; 6:2363-2370.
29. Harris L, Luftner D, Jager W, Robertson JF: c-erbB-2 in serum of patients with breast cancer. Int J Biol Markers 1999; 14:8-15.
30. Caruso ML, Valentini AM: Immunohistochemical p53 overexpression correlated to c-erbBb-2 and cathepsin D proteins in colorectal cancer. Anticancer Res 1996; 16:3813-3818.
31. Konno R, Takano T, Sato S, Yajima A: Serum soluble fas level as a prognostic factor in patients with gynecological malignancies. Clin Cancer Res 2000; 6:3576-3580.